Searched for
ABBVIE
US stocks: S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on IranUS market saw a mixed close as the S&P 500 and Nasdaq dipped, primarily due to tech giants like Alphabet facing investor scrutiny over AI s...- US stocks today: S&P 500, Dow tick higher as investors weigh Mideast negotiationsWall Street's major indexes opened little changed on Monday as investors returned from the long holiday weekend and awaited clarity on US-I...
- Micron Technology stock price jumps on Monday, shares up nearly 300 per cent for 2026U.S. Stock Market today: Micron Technology shares moved higher in premarket trading on Monday. AI-driven optimism has supported Wall Stree...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Alembic gets USFDA nod for generic levothyroxine sodium tabletsAlembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medicati...
- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- AbbVie in advanced talks to buy cancer drugmaker revolution medicines, shares jump nearly 30%AbbVie is in advanced talks to buy Revolution Medicines, a cancer drug company. The news pushed Revolution Medicines shares sharply higher....
- US President Donald Trump to announce new deals to lower drug prices, White House saysPresident Trump is set to announce new agreements Friday aimed at lowering prescription drug prices, with major drugmakers like AbbVie, Bri...
- Glenmark shares gain 2% as firm receives $700 million upfront payment from AbbVie dealGlenmark Pharmaceuticals' shares surged following its subsidiary's $700 million upfront payment from AbbVie for an exclusive licensing agre...
- Glenmark Pharma hits 10% upper circuit, scales fresh 52-week high on $700 mn cancer drug dealGlenmark Pharma Share Price: Glenmark Pharmaceuticals' shares soared after its subsidiary, Ichnos Glenmark Innovation, inked a global licen...
- Glenmark, AbbVie ink $700 million drug licensing dealGlenmark Pharmaceuticals has entered into a significant agreement with AbbVie to commercialize its investigational drug, ISB 2001, targetin...
- NMC starts probe against doctors over AbbVie-sponsored foreign tripsThe National Medical Commission has launched an investigation into doctors whose foreign trips, funded by AbbVie Healthcare, breached the U...
- AbbVie Healthcare India rejects wrongdoing allegations by the Department of PharmaceuticalsAbbVie Healthcare India has denied accusations of unethical marketing by the Department of Pharmaceuticals, asserting their compliance with...
- AbbVie Healthcare under government lens for 'violations'The department of pharmaceuticals (DoP) reprimanded AbbVie Healthcare India for unethical marketing practices involving over ₹1 crore spent...
- Novartis names new board member after international boss steps downNovartis has appointed AbbVie executive Patrick Horber to its executive committee, the Swiss pharmaceuticals maker said on Wednesday, after...
- Lupin gets USD 25 million from AbbVie for meeting key product development milestoneThe company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...
- AbbVie plans product launches in India from global portfolioIn addition, the drug maker is also considering making India part of its global Phase-3 clinical trials for potential therapies under devel...
- Lupin developing new products to treat cancer, other diseasesSharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to ...
- Lupin partners with AbbVie to develop, commercialise novel oncology drugAdditionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the...
- Dr Reddy's sued for 'infringement' of thyroid injection patentUS-based drug maker AbbVie Inc has dragged Dr Reddy's Lab to court for allegedly infringing the former's patented drug Zemplar on six count...
Load More
